JY
ONCY

Jeff Yass’s Oncolytics Biotech ONCY Stock Holding History

Jeff Yass’s Portfolio ONCY Stock Details ONCY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$127K Buy
134,129
+92,806
+225% +$86K ﹤0.01% 12315
2026
Q1 		$35.1K Buy
+41,323
New +$41.1K ﹤0.01% 12725
2025
Q2 		– Sell
-19,994
Closed -$11K – 13425
2025
Q1 		$11K Buy
+19,994
New +$14.6K ﹤0.01% 12208
2024
Q1 		– Sell
-30,306
Closed -$40.9K – 12999
2023
Q4 		$40.9K Buy
+30,306
New +$47.4K ﹤0.01% 11791
2022
Q3 		– Sell
-71,167
Closed -$70K – 13859
2022
Q2 		$70K Buy
+71,167
New +$86.5K ﹤0.01% 11770
2022
Q1 		– Sell
-10,059
Closed -$14K – 13695
2021
Q4 		$14K Buy
+10,059
New +$18.6K ﹤0.01% 12883
2019
Q2 		– Sell
-10,143
Closed -$19K – 10650
2019
Q1 		$19K Sell
10,143
-4,424
-30% -$8.96K ﹤0.01% 8597
2018
Q4 		$26K Buy
+14,567
New +$39.5K ﹤0.01% 8638

Other funds holding ONCY

Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
SI
Seeds Investor New York $973M AUM 33.7% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return
CCM
Connective Capital Management Palo Alto, California $142M AUM 51.29% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $7.56B AUM 44.87% 1-Year Est. Return
EFG
Everhart Financial Group Dublin, Ohio $1.56B AUM 34.29% 1-Year Est. Return
PI
PFG Investments Woodbury, New York $2.58B AUM 36.93% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

Jeff Yass's ONCY Position: Q2 2026 in Review

Jeff Yass increased its Oncolytics Biotech (ONCY) stake by 225% in Q2 2026, buying an estimated $86K and bringing the position to 134,129 shares worth $127K. The position accounts for ﹤0.01% of the portfolio, ranked #12315.

Jeff Yass first reported a position in ONCY in Q4 2018 and has held it in 8 quarters since. 76 funds tracked by Wall St. Rank hold ONCY as of Q2 2026.

  • Jeff Yass held 134,129 shares of Oncolytics Biotech worth $127K as of Q2 2026.
  • Jeff Yass bought 92,806 Oncolytics Biotech shares in Q2 2026, an estimated $86K.
  • Oncolytics Biotech made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #12315 holding.
  • Jeff Yass first reported a position in Oncolytics Biotech in Q4 2018 and has held it in 8 quarters since.
  • 76 funds tracked by Wall St. Rank held Oncolytics Biotech as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.